目次

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Segment Definition
1.1.1.1 Application Segment
1.1.1.2 Type Segment
1.1.1.3 End Use Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List Of Secondary Sources
1.11 List Of Abbreviations

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Application And Type Snapshot
2.3 End Use Snapshot
2.4 Competitive Landscape Snapshot

Chapter 3 Neurological Biomarkers Market Variables, Trends, And Scope
3.1 Neurological Biomarkers Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Penetration And Growth Prospect Mapping
3.3 Pipeline Analysis
3.3.1 Alzheimer’s Disease
3.3.2 Parkinson’s Disease
3.3.3 Multiple Sclerosis
3.3.4 Autism Spectrum Disorder
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Increasing Prevalence Of Neurological Diseases
3.4.1.2 Technological Advancements
3.4.1.3 Increased Funding For R&D In Biomarkers
3.4.2 Market Restraint Analysis
3.4.2.1 Lack Of Consumer Awareness
3.4.2.2 Reimbursement Policies
3.5 Neurological Biomarkers: Market Analysis Tools
3.5.1 Industry Analysis - Porter’s
3.5.2 Pestle Analysis

Chapter 4 Neurological Biomarkers Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)
4.1 Neurological Biomarkers Market: Type Movement Analysis
4.1.1 Genomic
4.1.1.1 Genomic Neurological Biomarkers Market, 2018 - 2030 (USD Million)
4.1.2 Proteomic
4.1.2.1 Proteomic Neurological Biomarkers Market, 2018 - 2030 (USD Million)
4.1.3 Metabolomic
4.1.3.1 Metabolomic Neurological Biomarkers Market, 2018 - 2030 (USD Million)
4.1.5 Imaging
4.1.5.1 Imaging Neurological Biomarkers Market, 2018 - 2030 (USD Million)
4.1.6 Others
4.1.6.1 Others Neurological Biomarkers Market, 2018 - 2030 (USD Million)

Chapter 5 Neurological Biomarkers Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
5.1 Neurological Biomarkers Market: Application Movement Analysis
5.1.1 Alzheimer’s Disease
5.1.1.1 Alzheimer’s Disease Market, 2018 - 2030 (USD Million)
5.1.2 Parkinson’s Disease
5.1.2.1 Parkinson’s Disease Market, 2018 - 2030 (USD Million)
5.1.3 Multiple Sclerosis
5.1.3.1 Multiple Sclerosis Market, 2018 - 2030 (USD Million)
5.1.4 Autism Spectrum Disorder
5.1.4.1 Autism Spectrum Disorder Market, 2018 - 2030 (USD Million)
5.1.5 Others
5.1.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 6 Neurological Biomarkers Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)
6.1 Neurological Biomarkers Market: End Use Movement Analysis
6.1.1 Research Organizations
6.1.1.1 Research Organizations Market, 2018 - 2030 (USD Million)
6.1.2 Pharma & Biotech Companies
6.1.2.1 Pharma & Biotech Companies Market, 2018 - 2030 (USD Million)
6.1.3 Clinical Diagnostics
6.1.3.1 Clinical Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 7 Neurological Biomarkers Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)
7.1 Regional Market Snapshot
7.2 North America
7.2.1 North America Neurological Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.2.2.2 Key Country Dynamics
7.2.2.3 Regulatory Framework
7.2.2.4 Reimbursement Scenario
7.2.3 Canada
7.2.3.1 Canada Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.2.3.2 Key Country Dynamics
7.2.3.3 Regulatory Framework
7.2.3.4 Reimbursement Scenario
7.2.4 Mexico
7.2.4.1 Mexico Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.2.4.2 Key Country Dynamics
7.2.4.3 Regulatory Framework
7.2.4.4 Reimbursement Scenario
7.3 Europe
7.3.1 Europe Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.3.2 Uk
7.3.2.1 Uk Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.3.2.2 Key Country Dynamics
7.3.2.3 Regulatory Framework
7.3.2.4 Reimbursement Scenario
7.3.3 Germany
7.3.3.1 Germany Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.3.3.2 Key Country Dynamics
7.3.3.3 Regulatory Framework
7.3.3.4 Reimbursement Scenario
7.3.4 Spain
7.3.4.1 Spain Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.3.4.2 Key Country Dynamics
7.3.4.3 Regulatory Framework
7.3.4.4 Reimbursement Scenario
7.3.5 France
7.3.5.1 France Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.3.5.2 Key Country Dynamics
7.3.5.3 Regulatory Framework
7.3.5.4 Reimbursement Scenario
7.3.6 Italy
7.3.6.1 Italy Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.3.6.2 Key Country Dynamics
7.3.6.3 Regulatory Framework
7.3.6.4 Reimbursement Scenario
7.3.7 Denmark
7.3.7.1 Denmark Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.3.7.2 Key Country Dynamics
7.3.7.3 Regulatory Framework
7.3.7.4 Reimbursement Scenario
7.3.8 Sweden
7.3.8.1 Sweden Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.3.8.2 Key Country Dynamics
7.3.8.3 Regulatory Framework
7.3.8.4 Reimbursement Scenario
7.3.9 Norway
7.3.9.1 Norway Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.3.9.2 Key Country Dynamics
7.3.9.3 Regulatory Framework
7.3.9.4 Reimbursement Scenario
7.4 Asia Pacific
7.4.1 Asia-Pacific Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Japan Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.4.2.2 Key Country Dynamics
7.4.2.3 Regulatory Framework
7.4.2.4 Reimbursement Scenario
7.4.3 China
7.4.3.1 China Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.4.3.2 Key Country Dynamics
7.4.3.3 Regulatory Framework
7.4.3.4 Reimbursement Scenario
7.4.4 India
7.4.4.1 India Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.4.4.2 Key Country Dynamics
7.4.4.3 Regulatory Framework
7.4.4.4 Reimbursement Scenario
7.4.5 South Korea
7.4.5.1 South Korea Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.4.5.2 Key Country Dynamics
7.4.5.3 Regulatory Framework
7.4.5.4 Reimbursement Scenario
7.4.6 Thailand
7.4.6.1 Thailand Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.4.6.2 Key Country Dynamics
7.4.6.3 Regulatory Framework
7.4.6.4 Reimbursement Scenario
7.4.7 Australia
7.4.7.1 Australia Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.4.7.2 Key Country Dynamics
7.4.7.3 Regulatory Framework
7.4.7.4 Reimbursement Scenario
7.5 Latin America
7.5.1 Latin America Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.5.2.2 Key Country Dynamics
7.5.2.3 Regulatory Framework
7.5.2.4 Reimbursement Scenario
7.5.3 Argentina
7.5.3.1 Argentina Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.5.3.2 Key Country Dynamics
7.5.3.3 Regulatory Framework
7.5.2.4 Reimbursement Scenario
7.6 MEA
7.6.1 MEA Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.6.2.2 Key Country Dynamics
7.6.2.3 Regulatory Framework
7.6.2.4 Reimbursement Scenario
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.6.3.2 Key Country Dynamics
7.6.3.3 Regulatory Framework
7.6.3.4 Reimbursement Scenario
7.6.4 UAE
7.6.4.1 UAE Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.6.4.2 Key Country Dynamics
7.6.4.3 Regulatory Framework
7.6.2.4 Reimbursement Scenario
7.6.5 Kuwait
7.6.5.1 Kuwait Neurological Biomarkers Market, 2018 - 2030 (USD Million)
7.6.5.2 Key Country Dynamics
7.6.5.3 Regulatory Framework
7.6.5.4 Reimbursement Scenario

Chapter 8 Neurological Biomarkers Market: Competitive Analysis
8.1 Company Categorization
8.2 Strategy Mapping
8.2.1 New Product Launch
8.2.2 Partnerships
8.2.3 Acquisition
8.2.4 Collaboration
8.2.5 Funding
8.3 Company Market Share Analysis, 2022
8.4 Company Profiles
8.4.1 Abbott
8.4.1.1 Company Overview
8.4.1.2 Financial Performance
8.4.1.3 Product Benchmarking
8.4.1.4 Strategic Initiatives
8.4.2 Johnson & Johnson Services, Inc.
8.4.2.1 Company Overview
8.4.2.2 Financial Performance
8.4.2.3 Product Benchmarking
8.4.2.4 Strategic Initiatives
8.4.3 Bio-Rad Laboratories, Inc.
8.4.3.1 Company Overview
8.4.3.2 Financial Performance
8.4.3.3 Product Benchmarking
8.4.3.4 Strategic Initiatives
8.4.4 Alseres Pharmaceuticals, Inc.
8.4.4.1 Company Overview
8.4.4.2 Product Benchmarking
8.4.5 Banyan Biomarkers, Inc.
8.4.5.1 Company Overview
8.4.5.2 Product Benchmarking
8.4.5.3 Strategic Initiatives
8.4.6 Rules-Based Medicine
8.4.6.1 Company Overview
8.4.6.2 Financial Performance
8.4.6.3 Product Benchmarking
8.4.6.4 Strategic Initiatives
8.4.7 Thermo Fisher Scientific, Inc.
8.4.7.1 Company Overview
8.4.7.2 Financial Performance
8.4.7.3 Product Benchmarking
8.4.7.4 Strategic Initiatives
8.4.8 Diagenic Asa
8.4.8.1 Company Overview
8.4.8.2 Product Benchmarking
8.4.9 Merck & Co., Inc.
8.4.9.1 Company Overview
8.4.9.2 Financial Performance
8.4.9.3 Product Benchmarking
8.4.9.4 Strategic Initiatives
8.4.10 Quanterix
8.4.10.1 Company Overview
8.4.10.2 Product Benchmarking
8.4.10.3 Strategic Initiatives

List of Tables
Table 1 List of Abbreviation
Table 2 North America neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 3 North America neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 4 North America neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 5 U.S. neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 7 U.S. neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 8 Canada neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 9 Canada neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 10 Canada neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 11 Mexico neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 12 Mexico neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 13 Mexico neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 14 Europe neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 15 Europe neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 16 Europe neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 17 UK neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 18 UK neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 19 UK neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 20 Germany neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 21 Germany neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 22 Germany neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 23 France neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 24 France neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 25 France neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 26 Italy neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 27 Italy neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 28 Italy neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 29 Spain neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 30 Spain neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 31 Spain neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 32 Denmark neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 33 Denmark neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 34 Denmark neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 35 Sweden neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 36 Sweden neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 37 Sweden neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 38 Norway neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 39 Norway neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 40 Norway neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 41 Asia Pacific neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 42 Asia Pacific neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 43 Asia Pacific neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 44 Japan neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 45 Japan neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 46 Japan neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 47 China neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 48 China neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 49 China neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 50 India neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 51 India neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 52 India neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 53 South Korea neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 54 South Korea neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 55 South Korea neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 56 Australia neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 57 Australia neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 58 Australia neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 59 Thailand neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 60 Thailand neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 61 Thailand neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 62 Latin America neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 63 Latin America neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 64 Latin America neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 65 Brazil neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 66 Brazil neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 67 Brazil neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 68 Argentina neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 69 Argentina neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 70 Argentina neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 71 MEA neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 72 MEA neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 73 MEA neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 74 South Africa neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 75 South Africa neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 76 South Africa neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 77 Saudi Arabia neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 78 Saudi Arabia neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 79 Saudi Arabia neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 80 UAE neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 81 UAE neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 82 UAE neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 83 Kuwait neurological biomarkers market, by application, 2018 - 2030 (USD Million)
Table 84 Kuwait neurological biomarkers market, by type, 2018 - 2030 (USD Million)
Table 85 Kuwait neurological biomarkers market, by end-use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Neurological biomarkers market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Segment snapshot (Type and application)
Fig. 11 Segment snapshot (End-use)
Fig. 12 Competitive landscape snapshot
Fig. 13 Biomarkers market value, 2022 (USD Million)
Fig. 14 Neurological biomarkers market dynamics
Fig. 15 Prevalence of Alzheimer's disease by age group, 2024
Fig. 16 Neurological biomarkers market: PORTER’s analysis
Fig. 17 Neurological biomarkers market: PESTLE analysis
Fig. 18 Neurological biomarkers market: Type outlook and key takeaways
Fig. 19 Neurological biomarkers market: Type movement analysis
Fig. 20 Genomic neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Proteomic neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Metabolomic neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Imaging market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Other neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Neurological biomarkers market: Application outlook and key takeaways
Fig. 26 Neurological biomarkers market: Application movement analysis
Fig. 27 Alzheimer’s disease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Parkinson’s disease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Multiple sclerosis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Autism spectrum disorder market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Neurological biomarkers market: End-use outlook and key takeaways
Fig. 33 Neurological biomarkers market: End-use movement analysis
Fig. 34 Research Organizations market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Pharma & Biotech Companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Clinical Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Neurological biomarkers market revenue, by region, 2022 & 2030 (USD Million)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Regional marketplace: Key takeaways
Fig. 40 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Key country dynamics
Fig. 42 U.S. neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Target disease prevalence
Fig. 44 Key country dynamics
Fig. 45 Canada neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Target disease prevalence
Fig. 47 Europe neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 UK neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Germany neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Target disease prevalence
Fig. 53 Key country dynamics
Fig. 54 France neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Italy neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Spain neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Denmark neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Sweden neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Norway neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Target disease prevalence
Fig. 66 Rest of Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Japan neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Target disease prevalence
Fig. 71 Key country dynamics
Fig. 72 China neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 India neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Target disease prevalence
Fig. 76 Key country dynamics
Fig. 77 Australia neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Thailand neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 South Korea neurological biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Rest of Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Latin America neurological biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Brazil neurological biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 Mexico neurological biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 Argentina neurological biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Rest of Latin America neurological biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 MEA neurological biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 South Africa neurological biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Target disease prevalence
Fig. 95 Key country dynamics
Fig. 96 Saudi Arabia neurological biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Target disease prevalence
Fig. 98 Key country dynamics
Fig. 99 UAE neurological biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Target disease prevalence
Fig. 101 Key country dynamics
Fig. 102 Kuwait neurological biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 Target disease prevalence
Fig. 104 Key payors in Kuwait
Fig. 105 Rest of MEA neurological biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 106 Key company categorization
Fig. 107 Company market positioning
Fig. 108 Company market share analysis, 2022
Fig. 109 Strategic framework